Covered recipient · General Payments record
MARK S ESKANDER
Allopathic & Osteopathic Physicians Orthopaedic Surgery Orthopaedic Surgery of the Spine
General Payments · PY2018–2024
$41,558.95
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $11,050.00 | 4 |
| Food and Beverage | $727.06 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Stryker Corporation | $11,208.83 | 8 |
| Medtronic, Inc. | $202.72 | 3 |
| Kuros Biosciences USA, Inc | $126.58 | 1 |
| Abbott Laboratories | $102.33 | 2 |
| PROVIDENCE MEDICAL TECHNOLOGY, INC. | $84.00 | 1 |
| BAXTER HEALTHCARE | $52.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $54.63 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124958313 | CMS |
| Abbott Laboratories | $47.70 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124958317 | CMS |
| Baxter Healthcare | $52.60 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118299845 | CMS |
| Kuros Biosciences USA, Inc | $126.58 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139157271 | CMS |
| Medtronic, Inc. | $102.04 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117144739 | CMS |
| Medtronic, Inc. | $86.04 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117144741 | CMS |
| Medtronic, Inc. | $14.64 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117144743 | CMS |
| Providence Medical Technology, Inc. | $84.00 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089608285 | CMS |
| Stryker Corporation | $1,950.00 | 01/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1119824013 | CMS |
| Stryker Corporation | $1,300.00 | 01/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1119824015 | CMS |
| Stryker Corporation | $3,250.00 | 02/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1119824017 | CMS |
| Stryker Corporation | $66.33 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119824019 | CMS |
| Stryker Corporation | $26.58 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119824021 | CMS |
| Stryker Corporation | $4,550.00 | 04/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1119824023 | CMS |
| Stryker Corporation | $26.92 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119824025 | CMS |
| Stryker Corporation | $39.00 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119824027 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.